AKBA
Akebia Therapeutics, Inc.
0.7065$
-4.8%
vs. previous close
Closing price · As of: Oct 30, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Akebia Therapeutics, Inc. (AKBA) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 10/23/2026 | Current report (8-K) | Akebia Therapeutics, Inc. (AKBA): Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | View report ↗ |
| 10/14/2026 | Current report (8-K) | Akebia Therapeutics, Inc. (AKBA): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers | View report ↗ |
| 08/05/2026 | Current report (8-K) | Akebia Therapeutics, Inc. (AKBA): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.